Dianthus Therapeutics (DNTH) Operating Expenses (2017 - 2025)
Dianthus Therapeutics (DNTH) posted quarterly Operating Expenses of $40.7 million for Q3 2025, up 26.85% year-over-year from $32.1 million in Q3 2024, and up 15.84% quarter-over-quarter from $35.1 million in Q2 2025.
Dianthus Therapeutics (DNTH) Operating Expenses (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Operating Expenses history runs 9 years deep, the most recent figure standing at $40.7 million for Q3 2025.
- In Q3 2025, Operating Expenses rose 26.85% year-over-year to $40.7 million; the TTM figure through Dec 2025 stood at $110.1 million (up 1.89% YoY), while the FY2024 annual figure was $108.1 million, up 111.96% from the prior year.
- Operating Expenses for Q3 2025 stood at $40.7 million, up from $35.1 million in the prior quarter.
- The five-year high for Operating Expenses was $40.7 million in Q3 2025, with the low at $8.2 million in Q1 2023.
- The 5-year median for Operating Expenses is $18.7 million (2021), against an average of $21.4 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 65.77% in 2023, then jumped 147.83% in 2024.
- Dianthus Therapeutics' Operating Expenses stood at $20.1 million in 2021, then tumbled by 41.07% to $11.9 million in 2022, then gained by 13.02% to $13.4 million in 2023, then surged by 147.83% to $33.2 million in 2024, then advanced by 22.39% to $40.7 million in 2025.
- Business Quant data shows DNTH's Operating Expenses at $40.7 million in Q3 2025, $35.1 million in Q2 2025, and $34.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Dianthus Therapeutics | 4.97 Bn | 4.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 40.68 Mn |
| Jun 30, 2025 | 35.12 Mn |
| Mar 31, 2025 | 34.34 Mn |
| Dec 31, 2024 | 33.24 Mn |
| Sep 30, 2024 | 32.07 Mn |
| Jun 30, 2024 | 24.07 Mn |
| Mar 31, 2024 | 18.72 Mn |
| Dec 31, 2023 | 13.41 Mn |
| Sep 30, 2023 | 16.68 Mn |
| Jun 30, 2023 | 12.75 Mn |
| Mar 31, 2023 | 8.16 Mn |
| Dec 31, 2022 | 11.87 Mn |
| Sep 30, 2022 | 9.43 Mn |
| Jun 30, 2022 | 18.08 Mn |
| Mar 31, 2022 | 23.83 Mn |
| Dec 31, 2021 | 20.14 Mn |
| Sep 30, 2021 | 18.25 Mn |
| Jun 30, 2021 | 17.61 Mn |
| Mar 31, 2021 | 18.70 Mn |
| Dec 31, 2020 | 19.07 Mn |